{"id":"W2276391444","doi":"10.1093/neuonc/nov300","title":"Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Bevacizumab; Temozolomide; Medicine; Placebo; Radiation therapy; Adverse effect; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005011344,0.000311951,0.001208158,0.0005919278,0.0002241719,0.0007533571,0.0003468146,0.0003790274,0.0006336225],"category_scores_gemma":[0.005492376,0.0001600414,0.001302853,0.0007792677,0.0001787198,0.0005169678,0.0003237669,0.0007056023,0.0001327861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001532257,"about_ca_system_score_gemma":0.002050737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002953299,"about_ca_topic_score_gemma":0.006469972,"domain_scores_codex":[0.997957,0.0009508636,0.0001799551,0.0001286682,0.0006319723,0.0001515816],"domain_scores_gemma":[0.9955687,0.0009416527,0.00212463,0.0001675763,0.0007579808,0.0004394837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05041799,0.002703673,0.1320157,0.002558243,0.005267805,0.0001970316,0.0003217399,0.004274063,0.007645669,0.0002555526,0.007086538,0.7872562],"study_design_scores_gemma":[0.005723213,0.07632443,0.8790408,0.0008444086,0.007470883,0.00103669,0.0001396488,0.002335958,0.006145073,0.0003952638,0.02045609,0.00008748005],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7835412,0.2050641,0.001585573,0.001667237,0.00009289512,0.0007037291,0.00255228,0.000149219,0.004643638],"genre_scores_gemma":[0.9383265,0.05174631,0.00146417,0.001042545,0.0002302273,0.0003257627,0.00567201,0.0000390303,0.001153518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005011344,"threshold_uncertainty_score":0.02650285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01716518308352756,"score_gpt":0.2854753499610148,"score_spread":0.2683101668774872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}